Government to approve sales of locally produced vaccine with adjuvant

Published: 2009-12-14 06:57:00

Updated: 2009-12-14 06:57:00

The government is likely to give the green light to a local pharmaceutical company to sell the nation's first vaccine for type-A (H1N1) influenza sooner or later, Korea Food and Drug Administration said on December 8.

Green Cross Corp. has completed its clinical tests for "Green Flu-S" and fou...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK